Among adolescents, the presentation of obstructive sleep apnea syndrome (OSAS) mirrors many typical signs of a much more common age-related diagnosis ...

Please provide your email address to receive an email when new articles are posted on . The PatientInsights 28-question survey from Phreesia was offered to patients with COPD in January 2025. Patients ...

Chronic obstructive pulmonary disease, or COPD, is the fourth leading cause of death worldwide, responsible for 3.5 million deaths in 2021, according to the World Health Organization. It’s a common ...

The path to market for Roche’s astegolimab became more uncertain after the investigational antibody failed to significantly lower disease exacerbation rates versus placebo in patients with chronic ...

Sly Stone, an icon of funk music, has died at the age of 82 following a prolonged battle with COPD, a chronic lung condition that can block airflow and cause difficulty breathing. "It is with profound ...

Background Little is known about the association between chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD) in people with established CVD. Knowing if COPD is associated ...

Jane Kim, MD, a board-certified internist and a member of Verywell's medical expert board, shares her insights on COPD symptoms and treatments. The symptoms of COPD aren’t always obvious. Subtle signs ...

For some patients with chronic obstructive pulmonary disease (COPD), summer can be one of the most stressful times of the year. Not only is allergy season in full swing, but rising temperatures and ...

Mepolizumab significantly reduced the annualized rate of moderate or severe exacerbations in COPD with an eosinophilic phenotype. Some 20% to 40% of COPD patients have elevated blood eosinophil counts ...

Who helps you manage your COPD? It’s more than just one doctor. It’s a medical care team. What Kind of Doctors Treat COPD? Your COPD care team includes providers who prescribe medicine, guide therapy ...

A greater increase in trough FEV1 induced by LAMA was noted in older patients who received a once-daily vs twice-daily regimen. Long-acting muscarinic antagonists (LAMA) significantly improve lung ...